UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SEC File Number:
FORM 12b-25 CUSIP Number:
NOTIFICATION OF LATE FILING
(Check One): ( ) Form 10-K ( ) Form 20-F ( ) Form 11-K (X)Form 10-Q
( ) Form N-SAR
For Period Ended:_______September 30, 1996
( ) Transition Report on Form 10-K
( ) Transition Report on Form 20-F
( ) Transition Report on Form 11-K
( ) Transition Report on Form 10-Q
( ) Transition Report on Form N-SAR
For the Transition Period Ended:_______________________________________
-------------------------------------------------------
Read Instructions (on back page) Before Preparing Form, Please Print or Type.
Nothing in this form shall be construed to imply that the Commission has
verified any information contained herein.
-------------------------------------------------------
If the notification relates to a portion of the filing checked above, identify
the Item(s) to which the notification relates:
________________________________________________________________________________
PART I - REGISTRANT INFORMATION
Packaging Research Corporation
________________________________________________________________________________
Full Name of Registrant
________________________________________________________________________________
Former Name if Applicable
2582 South Tejon Street
________________________________________________________________________________
Address of Principal Executive Office (Street and Number)
Englewood, Colorado 80110
________________________________________________________________________________
City, State and Zip Code
PART II - RULES 12b-25(b) and (c)
If the subject report could not be filed without unreasonable effort or expense
and the registrant seeks relief pursuant to Rule 12b-25(b), the following
should be completed. (Check box if appropriate)
(X) (a) The reasons described in reasonable detail in Part III of this
form could not be eliminated without unreasonable effort or
expense;
(X) (b) The subject annual report, semi-annual report, transition report
on Form 10-K, Form 20-F, 11K, Fork N-SAR , or portion thereof,
will be filed on or before the fifteenth calendar day following
the prescribed due date; or the subject quarterly report of
transition report on the Form 10-Q, or portion thereof will be
filed on or before the fifth calendar day following the
prescribed due date; and
( ) (c) The accountant's statement or other exhibit required by Rule
12b-25(c) has been attached is applicable.
PART III - NARRATIVE
State below in reasonable detail the reasons why the Form 10-K, 11-K, 10-Q,
N-SAR, or the transition report or portions thereof, could not be filed with the
prescribed time period. (Attach Extra Sheets if Needed)
The Registrant's form 10-Q for the quarter ended September 30, 1996 cannot be
filed within the perscribed time period due to the unavailability of certain
information required for the completion of the Company' financial statements as
of the quarter ended September 30, 1996. Such information could not be obtained
without unreasonable effort or expense.
PART IV - OTHER INFORMATION
(1) Name and telephone number of person to contact in regard to this
notification
Timothy G. Phillips 303 936-2363
______________________________________ _________ _________________________
(Name) (Area Code) (Telephone Number)
(2) Have all other periodic reports required under Section 13 or 15(d) of the
Securities Exchange Act of 1934 or Section 30 of the Investment Company Act
of 1940 during the preceding 12 months (or for such shorter) period that
the registrant was required to file such reports) been filed? If answer
is no identify report(s). YES __X__ NO _____
________________________________________________________________________________
(3) It is anticipated that any significant change in results of operations from
the corresponding period for the last fiscal year will be reflected by the
earnings statements to be included in the subject report or portion thereof?
YES __X__ NO _____
If so, attach an explanation of the anticipated change, both narratively
and quantitatively, and, if appropriate, state the reasons why a reasonable
estimate of the results cannot be made.
Packaging Research Corporation
_______________________________________________________
(Name of Registrant as Specified in Charter)
has caused this notification to be signed on its behalf by the undersigned here-
unto duly authorized.
November 14, 1996 /s/ Timothy G. Phillips
Date:_______________________________ By:_______________________________________
Timothy G. Phillips
President, CEO
INSTRUCTION: The form may be signed by an executive officer of the
registrant or by any other duly authorized representative. The name and title of
the person signing the form shall be typed or printed beneath the signature. If
the statement is signed on behalf of the registrant by an authorize
representative (other than the executive officer), evidence of the
representative's authority to sign on behalf of the registrant shall be filed
with the form.
-------------------------------------------------------
ATTENTION
Intentional misstatements or omissions of fact constitute
Federal Criminal Violations (See 18 U.S.C. 1001).l
-------------------------------------------------------
1. This form is required by Rule 12b-25 (17 CFR 240, 12b-25) of the General
Rules and Regulations under the Securities Exchange Act of 1934.
2. One signed original and four conformed copies of this form and amendments
thereto must be completed and filed with the Securities and Exchange
Commission, Washington, D.C. 20549, in accordance with Rule 0-3 of the
General Rules and Regulations under the Act. The information contained in or
filed with the form will be made a matter of public record in the Commission
files.
3. A manually signed copy of the form and amendments thereto shall be filed
with each nations securities exchange on which any class of securities of
the registrant is registered.
4. Amendments to the notifications must also be filed on form 12b-25 but need
not restate information that has been correctly furnished. The form shall
be clearly identified as an amended notification.
<PAGE>
In response to PART IV-OTHER INFORMATION the following is an explanation of
anticipated significant changes in current period results of operations from the
corresponding period for the last fiscal year:
On August 12, 1996, the Board of Directors of the Company approved the sale
and liquidation of its 97.4% owned subsidiary, Mama Rizzo's, Inc. ("MRI").
It is anticipated that the quarter ended September 30, 1996 will reflect
significant losses as compared to the quarter ended September 30, 1995.
These losses are primarily attributable to the write-down of the assets of
MRI to estimated net realizable values and the estimated costs of disposal.
